Literature DB >> 7548837

Induction of apoptosis by tumor suppressor genes and oncogenes.

C E Canman1, M B Kastan.   

Abstract

The p53 tumor suppressor gene product, and the bcr-abl, bcl-2, and c-myc gene products all appear to influence the susceptibility of cells to apoptosis. In addition to the role p53 protein plays in mediating a cell cycle arrest in G1 following DNA damage, p53 also performs functions critical for removal of damaged cells by initiating apoptosis in certain physiological situations. Cells which express deregulated c-myc are sensitized to apoptosis following various growth suppressing stimuli and these observations have provided new insights into how apoptosis-suppressing genes such as mutant p53, bcl-2 and bcr-abl may cooperate during transformation and how they might influence the sensitivity of cells to radiation and chemotherapy.

Entities:  

Mesh:

Year:  1995        PMID: 7548837     DOI: 10.1006/scbi.1995.0003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  15 in total

1.  AP-1 repressor protein JDP-2: inhibition of UV-mediated apoptosis through p53 down-regulation.

Authors:  F Piu; A Aronheim; S Katz; M Karin
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis.

Authors:  C Koumenis; A Giaccia
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

3.  Expression of apoptosis-related markers in malignant epithelial tumours of the lacrimal gland and their relation to clinical outcome.

Authors:  Diego Strianese; Gianluca Baldi; Stefania Staibano; Alfonso Baldi; Gaetano De Rosa; Fausto Tranfa; Giulio Bonavolontà
Journal:  Br J Ophthalmol       Date:  2007-04-12       Impact factor: 4.638

Review 4.  Radiation enteritis.

Authors:  Mike M Bismar; Frank A Sinicrope
Journal:  Curr Gastroenterol Rep       Date:  2002-10

5.  Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.

Authors:  Christophe Le Clorennec; Tan-Sothéa Ouk; Ibtissam Youlyouz-Marfak; Stéphanie Panteix; Catherine-Claude Martin; Julia Rastelli; Eric Adriaenssens; Ursula Zimber-Strobl; Jean Coll; Jean Feuillard; Chantal Jayat-Vignoles
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

6.  Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway.

Authors:  B Rayet; J A Lopez-Guerrero; J Rommelaere; C Dinsart
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 7.  Targeting apoptotic caspases in cancer.

Authors:  Ashley Boice; Lisa Bouchier-Hayes
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-02-19       Impact factor: 4.739

8.  Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.

Authors:  Sydney X Lu; Lucy W Kappel; Anne-Marie Charbonneau-Allard; Renée Atallah; Amanda M Holland; Claire Turbide; Vanessa M Hubbard; Jimmy A Rotolo; Marsinay Smith; David Suh; Christopher King; Uttam K Rao; Nury Yim; Johanne L Bautista; Robert R Jenq; Olaf Penack; Il-Kang Na; Chen Liu; George Murphy; Onder Alpdogan; Richard S Blumberg; Fernando Macian; Kathryn V Holmes; Nicole Beauchemin; Marcel R M van den Brink
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

9.  Temperature sensitivity of human wild-type and mutant p53 proteins expressed in vivo.

Authors:  F Ponchel; J Milner
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

10.  Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression.

Authors:  J Rak; Y Mitsuhashi; V Erdos; S N Huang; J Filmus; R S Kerbel
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.